ConferenceHealth Econ · June 2026
This study investigated the impact of providing feedback to respondents on a dominance-structured choice task on subsequent choice behavior in a discrete choice experiment (DCE). The DCE was conducted among 626 patients with heart failure. Respondents were ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · February 20, 2022
47 Background: Practice guidelines have been modified to recommend hereditary and tumor gene mutation testing in patients with metastatic castration-resistant prostate cancer (mCRPC) to identify patients for molecularly targeted ...
Full textCite
ConferenceJournal of Clinical Oncology · September 20, 2019
318 Background: ASCO Quality Oncology Practice Initiative (QOPI) encourages hospitals to determine if patients (pts) with stage IV NSCLC adenocarcinoma have activating EGFR mutations. Guidelines recommend tumor testing to identif ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2019
5558 Background: Maintenance therapy with PARP inhibitors has become prevalent in treating ovarian cancer. However, the preferences of women with ovarian cancer regarding the risks, side effects and benefits afforded by maintenan ...
Full textCite
ConferenceDiabetes · July 1, 2018
Objectives: To evaluate the effect of exenatide 2mg once-weekly vs. placebo in addition to usual care on medical resource use among 14,572 patients with type 2 diabetes enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL), whic ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
TPS10128 Background: Adjuvant endocrine therapy (AET) is a crucial component of treatment used to prevent recurrence and reduce mortality for women with hormone receptor positive breast cancer. Poor adherence to AET is a signific ...
Full textCite
ConferenceJournal of Clinical Oncology · March 1, 2016
32 Background: The Oncotype DX (ODX) multigene assay has been previously suggested to result in an overall reduction in the use of adjuvant chemotherapy and associated costs for women with early stage, estrogen receptor (ER)-posi ...
Full textCite
ConferenceJ Palliat Med · November 2015
BACKGROUND: In recent years, palliative treatment of prostate cancer metastases has been characterized by the use of more complex radiation treatment, despite a lack of evidence demonstrating a clinical benefit of these technologies in the palliative setti ...
Full textLink to itemCite
ConferenceBlood · November 16, 2006
AbstractBackground: Our previous cost-effectiveness analysis of first-line imatinib versus interferon- plus low-dose cytarabine in newly diagnosed patients with CML in the chronic phase was based on a median ...
Full textCite